CODX vs SPY
Co-Diagnostics, Inc. Common Stock (CODX) versus SPDR S&P 500 ETF Trust (SPY) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
SPDR S&P 500 ETF Trust (SPY) common stock listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
SPY does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. SPY currently screens at market cap $0.
Not investment advice. Open the CODX and SPY stock pages for the full models.
Not investment advice.